Baird Financial Group
FBT icon

Baird Financial Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Baird Financial Group’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.88M Buy
34,276
+13,195
+63% +$2.73M 0.01% 649
2025
Q4 		$4.35M Buy
21,081
+12,614
+149% +$2.52M 0.01% 777
2025
Q3 		$1.52M Buy
8,467
+428
+5% +$72.9K ﹤0.01% 1137
2025
Q2 		$1.3M Buy
8,039
+916
+13% +$146K ﹤0.01% 1142
2025
Q1 		$1.21M Sell
7,123
-585
-8% -$102K ﹤0.01% 1117
2024
Q4 		$1.28M Buy
7,708
+718
+10% +$123K ﹤0.01% 1100
2024
Q3 		$1.2M Sell
6,990
-686
-9% -$114K ﹤0.01% 1118
2024
Q2 		$1.18M Buy
7,676
+1,031
+16% +$155K ﹤0.01% 1111
2024
Q1 		$1.02M Buy
6,645
+1,070
+19% +$163K ﹤0.01% 1154
2023
Q4 		$881K Sell
5,575
-6,423
-54% -$923K ﹤0.01% 1177
2023
Q3 		$1.76M Buy
11,998
+1,320
+12% +$201K ﹤0.01% 945
2023
Q2 		$1.64M Buy
10,678
+5,706
+115% +$890K ﹤0.01% 974
2023
Q1 		$771K Buy
4,972
+602
+14% +$94.6K ﹤0.01% 1175
2022
Q4 		$673K Sell
4,370
-109
-2% -$16.1K ﹤0.01% 1178
2022
Q3 		$591K Sell
4,479
-98
-2% -$13.8K ﹤0.01% 1230
2022
Q2 		$620K Sell
4,577
-1,579
-26% -$218K ﹤0.01% 1262
2022
Q1 		$918K Sell
6,156
-7
-0.1% -$1.03K ﹤0.01% 1180
2021
Q4 		$998K Buy
6,163
+511
+9% +$82.6K ﹤0.01% 1201
2021
Q3 		$939K Sell
5,652
-7,047
-55% -$1.2M ﹤0.01% 1223
2021
Q2 		$2.19M Sell
12,699
-5,245
-29% -$866K 0.01% 885
2021
Q1 		$2.88M Buy
17,944
+246
+1% +$42.1K 0.01% 752
2020
Q4 		$2.97M Buy
17,698
+6,600
+59% +$1.07M 0.01% 687
2020
Q3 		$1.75M Sell
11,098
-11,890
-52% -$1.94M 0.01% 780
2020
Q2 		$3.86M Buy
22,988
+13,513
+143% +$2.12M 0.01% 540
2020
Q1 		$1.24M Sell
9,475
-265
-3% -$37.8K 0.01% 827
2019
Q4 		$1.45M Sell
9,740
-14,557
-60% -$2M 0.01% 865
2019
Q3 		$3.01M Sell
24,297
-61,586
-72% -$8.2M 0.01% 656
2019
Q2 		$12.1M Buy
85,883
+48,481
+130% +$6.69M 0.05% 330
2019
Q1 		$5.64M Sell
37,402
-725
-2% -$104K 0.03% 416
2018
Q4 		$4.74M Buy
38,127
+16,091
+73% +$2.2M 0.03% 429
2018
Q3 		$3.47M Buy
22,036
+11,317
+106% +$1.71M 0.02% 538
2018
Q2 		$1.5M Sell
10,719
-110
-1% -$15.1K 0.01% 730
2018
Q1 		$1.44M Sell
10,829
-248
-2% -$33.9K 0.01% 726
2017
Q4 		$1.38M Sell
11,077
-294
-3% -$36.3K 0.01% 738
2017
Q3 		$1.41M Sell
11,371
-104
-0.9% -$12.3K 0.01% 706
2017
Q2 		$1.31M Buy
11,475
+7,250
+172% +$780K 0.01% 717
2017
Q1 		$445K Buy
4,225
+85
+2% +$8.52K ﹤0.01% 977
2016
Q4 		$376K Buy
4,140
+69
+2% +$6.46K ﹤0.01% 992
2016
Q3 		$406K Sell
4,071
-542
-12% -$53.2K ﹤0.01% 979
2016
Q2 		$427K Sell
4,613
-942
-17% -$86.5K ﹤0.01% 953
2016
Q1 		$486K Sell
5,555
-43,889
-89% -$3.87M ﹤0.01% 925
2015
Q4 		$5.59M Buy
49,444
+10,408
+27% +$1.12M 0.06% 318
2015
Q3 		$3.96M Buy
39,036
+5,831
+18% +$693K 0.04% 378
2015
Q2 		$4.12M Buy
+33,205
New +$4.01M 0.04% 394

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Baird Financial Group's FBT Position: Q1 2026 in Review

Baird Financial Group increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 63% in Q1 2026, buying an estimated $2.73M and bringing the position to 34,276 shares worth $6.88M. The position accounts for 0.01% of the portfolio, ranked #649.

Baird Financial Group first reported a position in FBT in Q2 2015 and has held it in 44 quarters since. The position peaked at $12.1M in Q2 2019. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Baird Financial Group held 34,276 shares of First Trust NYSE Arca Biotechnology Index Fund worth $6.88M as of Q1 2026.
  • Baird Financial Group bought 13,195 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $2.73M.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of Baird Financial Group's portfolio in Q1 2026, its #649 holding.
  • Baird Financial Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2015 and has held it in 44 quarters since.
  • Baird Financial Group's First Trust NYSE Arca Biotechnology Index Fund position peaked at $12.1M in Q2 2019.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Baird Financial Group's 13F filing for Q1 2026, filed 14 May 2026.